Related Experiment Video
Updated: Jul 3, 2026

Three-Dimensionally Printed Microfluidic Cross-flow System for Ultrafiltration/Nanofiltration Membrane Performance Testing
Published on: February 13, 2016
Rejection of pharmaceuticals in nanofiltration and reverse osmosis membrane drinking water treatment
J Radjenović1, M Petrović, F Ventura
1Department of Environmental Chemistry, IIQAB-CSIC, Barcelona, Spain. jrdqam@cid.csic.es
Abstract:
This paper investigates the removal of a broad range of pharmaceuticals during nanofiltration (NF) and reverse osmosis (RO) applied in a full-scale drinking water treatment plant (DWTP) using groundwater. Pharmaceutical residues detected in groundwater used as feed water in all five sampling campaigns were analgesics and anti-inflammatory drugs such as ketoprofen, diclofenac, acetaminophen and propyphenazone, beta-blockers sotalol and metoprolol, an antiepileptic drug carbamazepine, the antibiotic sulfamethoxazole, a lipid regulator gemfibrozil and a diuretic hydrochlorothiazide. The highest concentrations in groundwater were recorded for hydrochlorothiazide (58.6-2548ngL(-1)), ketoprofen (
Related Concept Videos
Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration
Drug Elimination by Renal Route: Tubular Reabsorption
Dialysis
Downstream Processing
Osmosis and Osmotic Pressure of Solutions
Physical Methods for Controlling Microbial Growth: Radiation and Filtration

